Feature Channels: Biotech

Filters close
Newswise: Scientist Awarded National Institutes of Health Grant to Examine Cancer-Dependent Enzyme
Released: 13-Sep-2024 12:05 PM EDT
Scientist Awarded National Institutes of Health Grant to Examine Cancer-Dependent Enzyme
Virginia Tech

During every moment of any living organism’s life, enzymes are at work. These crucial proteins support life through most biological processes, including metabolism, movement, respiration, and digestion. “Enzymes’ effects in cells are part of normal physiology,” said Kathleen Mulvaney, assistant professor at Virginia Tech’s Fralin Biomedical Research Institute.

Newswise: funda_meric-bernstam.jpg.resize.405.575.high.jpg
Released: 13-Sep-2024 9:05 AM EDT
ESMO: Novel ADC AZD8205 Demonstrates Manageable Safety Profile and Preliminary Efficacy in First-in-Human Trial
University of Texas MD Anderson Cancer Center

The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with similar ADCs and initial efficacy in heavily pretreated patients with advanced or metastatic solid tumors, according to interim data shared today at the 2024 European Society for Medical Oncology (ESMO) Congress by researchers from The University of Texas MD Anderson Cancer Center.

Newswise: Iowa State Leads a 'Dream' Project to Catalog Livestock DNA Regulatory Regions
Released: 12-Sep-2024 5:05 PM EDT
Iowa State Leads a 'Dream' Project to Catalog Livestock DNA Regulatory Regions
Iowa State University

A new USDA-supported project based at Iowa State University will create an encyclopedia of livestock species' genetic regulatory regions, a DNA netherworld that could be useful in breeding for improved animal efficiency and health.

Newswise: Unlocking Plant Potential: Regulating Nature's Chemical Wealth Through Splicing
Released: 12-Sep-2024 12:05 PM EDT
Unlocking Plant Potential: Regulating Nature's Chemical Wealth Through Splicing
Chinese Academy of Sciences

A recent study highlights the pivotal role of alternative splicing in controlling plant secondary metabolism, which is crucial for producing bioactive compounds with significant medicinal and industrial value.

Newswise: 1920_biomanufacturing-center-cedars-sinai.jpg?10000
Released: 12-Sep-2024 10:05 AM EDT
New Resource for California Stem Cell Scientists
Cedars-Sinai

The Cedars-Sinai Board of Governors Regenerative Medicine Institute is creating a resource laboratory to help advance stem cell-based technologies throughout Cedars-Sinai and across California.

Released: 12-Sep-2024 10:05 AM EDT
Using a Molecular Scissors to Improve CAR-T Cell Therapy
Mayo Clinic

Mayo Clinic researchers mined the molecular foundations of cancer and uncovered a new reason chimeric antigen receptor (CAR-T cell therapy) fails in some patients. This discovery has fueled new strategies that incorporate antibodies and gene editing to improve the outcome of this breakthrough treatment for patients.

Newswise: The Olive Tree's Blueprint: Key Insights Into High-Quality Oil Production
Released: 11-Sep-2024 12:05 PM EDT
The Olive Tree's Blueprint: Key Insights Into High-Quality Oil Production
Chinese Academy of Sciences

A pivotal study has decoded the genetic basis of olive oil production, revealing a key regulatory mechanism that shapes oil biosynthesis. By mapping the olive tree’s genome and metabolic pathways, researchers have identified how MYC2, a critical transcription factor, orchestrates the balance between fatty acid and flavonoid synthesis.

Newswise: Sustaining health and wealth: advancing sanchi ginseng production
Released: 11-Sep-2024 11:05 AM EDT
Sustaining health and wealth: advancing sanchi ginseng production
Chinese Academy of Sciences

A recent study sheds light on Panax notoginseng, also known as Sanchi, by delving into its phytochemical profile and pharmacological potential. The research provides an in-depth review of the biosynthesis and regulation of ginsenosides, the herb's primary bioactive compounds known for their therapeutic effects.

Newswise: Decoding atractylodes lancea: a genomic journey through adaptation and metabolism
Released: 11-Sep-2024 11:05 AM EDT
Decoding atractylodes lancea: a genomic journey through adaptation and metabolism
Chinese Academy of Sciences

Scientists have decoded the genetic blueprint of Atractylodes lancea, a prized herb in traditional Chinese medicine. Through comprehensive genome resequencing, the study unveils how natural variations drive the plant's evolution and metabolic adaptations, particularly affecting the production of key medicinal compounds.

Newswise: PA State Senator Aument Recognized for His Support of Research at SHRO
Released: 11-Sep-2024 10:05 AM EDT
PA State Senator Aument Recognized for His Support of Research at SHRO
Sbarro Health Research Organization (SHRO)

Temple University’s Sbarro Institute for Cancer Research and Molecular Medicine has benefited from the support of Pennsylvania State Sen. Ryan Aument since he took office in 2014.

Newswise:Video Embedded carbohydrate-polymers-could-be-a-sweet-solution-for-water-purification
VIDEO
6-Sep-2024 8:00 AM EDT
Carbohydrate polymers could be a sweet solution for water purification
American Chemical Society (ACS)

Researchers in ACS Central Science report a sugar-like polymer that traps heavy metals within insoluble clumps for easy removal. In proof-of-concept tests, the polymer removed ionic cadmium and lead from river water spiked with these persistent contaminants.

Newswise: Fungal Foe Fended Off: DNA Demethylation Boosts Tomato Resistance
Released: 11-Sep-2024 6:05 AM EDT
Fungal Foe Fended Off: DNA Demethylation Boosts Tomato Resistance
Chinese Academy of Sciences

A recent study discovered that applying 5-Azacytidine, a DNA methylation inhibitor, significantly reduces tomato susceptibility to gray mold, a common postharvest fungal disease. This epigenetic strategy enhances the fruit's natural defense system, offering a sustainable and innovative method to boost crop resistance without genetic modification.

Released: 10-Sep-2024 4:05 PM EDT
TORL BioTherapeutics Announces Appointment of Howard A. "Skip" Burris III, MD, FACP, FASCO as Board Member
TORL Biotherapeutics LLC

TORL BioTherapeutics, LLC (TORL), a clinical stage biotechnology company discovering and developing new antibody-based immunotherapies to improve and extend the lives of patients with cancer worldwide, today announced the appointment of Howard A. "Skip" Burris III, MD, FACP, FASCO as Board Member.

Newswise: Unlocking plant defense: bacterial hijacking exposed
Released: 10-Sep-2024 8:05 AM EDT
Unlocking plant defense: bacterial hijacking exposed
Chinese Academy of Sciences

A recent study has uncovered how the pathogen Ralstonia solanacearum disrupts plant defenses through its type III effector RipAF1. The research shows that RipAF1 modifies a critical plant protein, FBN1, via ADP-ribosylation, which alters the plant’s hormonal signaling balance, suppressing jasmonic acid (JA) and enhancing salicylic acid (SA) pathways.

Newswise: Boosting Cannabis Production: The Science Behind Bud Abundance
Released: 10-Sep-2024 6:05 AM EDT
Boosting Cannabis Production: The Science Behind Bud Abundance
Chinese Academy of Sciences

Scientists have identified a crucial gene, CsMIKC1,that controls the number of flowering sites in Cannabis sativa, a finding that could significantly enhance both medicinal and grain yields. The study reveals how CsMIKC1 drives inflorescence development, offering new pathways to boost productivity in Cannabis cultivation.

Released: 9-Sep-2024 4:05 PM EDT
Researchers at UCLA Identify Cellular Pathways Whose Dysregulation Leads to Acne Lesions
University of California, Los Angeles (UCLA), Health Sciences

Using cutting-edge bioinformatics techniques for gene identification and sequencing, researchers at UCLA are comprehensively map signaling pathway distributions in both normal and acne-affected skin.

5-Sep-2024 10:05 AM EDT
FASEB Selects Howard Garrison Advocacy Fellows
Federation of American Societies for Experimental Biology (FASEB)

The Federation of American Societies for Experimental Biology (FASEB) selected nine scientists as the 2024 Howard Garrison Advocacy Fellows.

Released: 9-Sep-2024 10:05 AM EDT
Cancer Research in Space for Life on Earth: Wake Forest Institute for Regenerative Medicine Selected Through International Space Station National Lab Solicitation in Partnership with NASA
Atrium Health Wake Forest Baptist

The Wake Forest Institute for Regenerative Medicine (WFIRM) is honored to announce its selection for a pioneering cancer research project that will take place aboard the International Space Station (ISS).



close
2.82734